Selective botulinum toxin injection in the treatment of recurrent deformity following surgical correction of club foot: a preliminary report of 3 children.
Management of a child with club foot deformity that recurs after an apparently successful posteromedial soft tissue release remains a challenge. Revision surgery is often attempted, but this carries a high risk of significant scarring or neurovascular complications. We have treated 3 children (3 feet) with relapsed club foot and fixed deformities, using Botulinum toxin A (BTX-A) injection into muscle groups clinically thought to be responsible for recurrent deformity, followed by moulded plaster casts. Two cases have maintained a good foot position with an minimum follow-up of 18 months, and one other is also doing well having had a tibialis anterior tendon transfer as well as the BTX-A therapy. In our limited experience, targeted BTX-A injection with plaster casting has been safe, and may obviate the need for major revision surgery in a proportion of cases with recurrent club foot deformity following previous posteromedial soft tissue release.
Mitchell
Piers D
PD
West Middlesex University Hospital, Isleworth, Middlesex TW7 6AF, UK.
Tisdall
Martin
M
Zadeh
Hamid G
HG
D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D002370:Casts, Surgical; D003025:Clubfoot / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D012008:Recurrence
D019274:Botulinum Toxins, Type A